Study contact information See details of ourperformance for all clinical trials reported to the NIHR, for the Initiation and Delivery of studies in the period from 1 October 2020 to 31 March 2021. Pulmonary epithelial barrier and immunological functions at birth and in early life: key determinants of the development of asthma? Name:Dr Amanda NatanekEmail:A.Natanek@rbht.nhs.uk. Specialist centre for the treatment of heart and lung disease Royal Brompton and Harefield hospitals make up the largest specialist heart and lung centre in the UK and among the largest in Europe. A drug utilization study (DUS) of alirocumab in Europe to assess the effectiveness of the dosing recommendation to avoid very low LDL-C levels. Name: Lisa BrightonEmail:L.Brighton@rbht.nhs.uk, Study 21+. A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial, Study contact information Name:Carmen ChanEmail:L.Chan2@rbht.nhs.uk, Study Name:Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study Benjamin Garfield's research works | Royal Brompton and Harefield NHS This study aims to provide a contemporary, population-level assessment of the true clinical burden of myocarditis and how this may have changed over the last 20 years. Study contact information The Clinical and psychosocial impact of COVID-19 on patients with neuromuscular and neurological disorders, Study contact information Professor David Firmin, Study Can thrombosis and fibrinolysis markers in patients undergoing aortic valve replacement predict outcome, Study contact information 707 S Garfield Ave Ste 201, Alhambra, CA, 91801 . Development and validation of the use of Video games and virtual reality to enable Autonomous Remote monitoring of OTotoxicity in high-risk population groups (VAROT). Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study, Study contact information Name:Professor Susanna PriceEmail: s.price@rbht.nhs.uk, Principal investigator Tous les types; Assurance; Dentiste A study of single doses to evaluate the safety, tolerability, pharmacokinetics and target engagement of nebulised GSK3008348 in Idiopathic Pulmonary Fibrosis patients, using positron emission tomography (PET) imaging, Study contact information Find out more. A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension, Study Study contact information HElping Alleviate the Longer-term consequences of COVID-19(HEAL-COVID): a national platform trial, Study contact information Name:Dr Shouvik HaldarEmail:S.Haldar@rbht.nhs.uk, Study Investigation of Post-Myocardial Infarction Left Ventricular Remodelling By Diffusion Tensor Cardiac Magnetic Resonance. Genetics of susceptibility and mortality in critical care (GenOMICC), Study contact information A case-referent study of the exposure history of adults with hypersensitivity pneumonitis, Study contact information AI & radiomics for Stratification Of lung Nodules After Radically treated cancer, Study contact information Dr Mario Petrou & Dr Sunil Bhudia, Study Fissure Closure with the AeriSeal System for Converting Collateral Ventilation Status in Patients with Severe Emphysema a Multicenter, Prospective Trial, Study contact information Study Name:Louise SelbyEmail:L.Selby@rbht.nhs.uk, Study Study contact information Name: Dr Mahmoud BarbirEmail: M.Barbir@rbht.nhs.uk. A cross sectional feasibility study examining the relationship between peak cough flow and respiratory function testing (spirometry) post bilateral sequential single lung transplantation, at a single centre cardiothoracic transplantation unit, Study contact information Name:Deirdre FlanneryEmail:D.Flannery@rbht.nhs.uk, Study A Phase 3, Randomized, Double-blind, Placebo-controlled study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate-and High-risk PAH Patients. dr benjamin garfield brompton hospital - eventup.live Study contact information Dr Julene S Carvalho, Study Dr Vasileios Panoulas, Study Fingerprinting proteoglycan turnover by ADAMTS proteases in the cardiovasculature, Study contact information Study A feasibility study to assess Novel Electronic Monitoring Devices (NEDM) for monitoring adherence in children with asthma. A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older, Study contact information Study contact information A double-blind, placebo-controlled study to assess the effects of inhaled PC945 in the treatment of culture-positive Aspergillus fumigatus infection in subjects with moderate to severe asthma, Study contact information A 52 week, double blind, randomised, placebo-controlled trial evaluating the effect of Nintedanib, 150 mg twice daily, on annual rate of decline in Forced Vital Capacity and safety in patients with RA associated ILD with UIP pattern, Study Jordan Bloom, MD, MPH is a cardiac surgeon who performs the full spectrum of adult cardiac surgery including coronary bypass, valvular repair/replacements and aortic surgery. Real-world experience of dupilumab for the treatment of severe asthma in the United Kingdom: a retrospective study. Surgical oncology team | Royal Brompton & Harefield hospitals Professor Susanna Price, Study A Phase 3 study of the long-term safety of a triple combination therapy of VX-445, tezacaftor and ivacaftor in people with cystic fibrosis aged 12 and older. Name:Dr Louise FlemingEmail:l.fleming@rbht.nhs.uk, Study A Phase 3, open label, rollover study to evaluate the safety and efficacy of long term treatment with VX 661 in combination with Ivacaftor in subjects aged 12 years and older with Cystic Fibrosis , homozygous or heterozygous for the F508del CFTR mutation, Study contact information Ventilation Strategies in COVID-19; CPAP, High-flow, and standard care, Study contact information Study contact information Name:Lydia SpurrEmail:l.spurr@rbht.nhs.uk, Study Homepage | Royal Brompton & Harefield hospitals NEw Understanding of the tReatment Of COUGH (NEUROCOUGH) European Chronic Cough Registry and Bio-Resource Protocol. Name:Dr Sandra ScottEmail: s.scott@rbht.nhs.uk. Dr.Penisson Laurence . The use of home-monitoring and mHealth systems to predict asthma control and asthma exacerbations, Study contact information GALACTIC-1 - A randomised, double-blind, multicentre, parallel, placebo controlled Phase 2b study in subjects with idiopathic pulmonary fibrosis (IPF) investigating the efficacy and safety of TD139, an inhaled galectin-3 inhibitor administered via a dry powder. Interstitial Lung Disease DNA Study, Study contact information Name:Mahitha GummadiEmail:M.Gummadi@rbht.nhs.uk, Study Name: Dr Sundeep KaulEmail: s.kaul@rbht.nhs.uk, Study Study contact informationName: Abigail WatsonEmail: a.watson2@rbht.nhs.uk. Asthma Atrial fibrillation Bronchiectasis Cancer Chronic cough Chronic Obstructive Pulmonary Disease (COPD) Chronic respiratory disease Congenital heart disease Cystic fibrosis Eisenmenger syndrome Genetics Heart failure Idiopathic pulmonary fibrosis Imaging Intensive care Interstitial Lung Disease Kawasaki disease Lung cancer Myocardial infarction Name:Maria NunezEmail: M.Nunez@rbht.nhs.uk, Principal investigator Royal Brompton Hospital is a regional centre for pulmonary hypertension in the UK. Effect of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock, Study contact informationName: Alcida BucajEmail: A.Bucaj@rbht.nhs.uk, Study A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel Arm, Phase 2b Study to Evaluate the Efficacy and Safety of Multiple Doses of BLU-5937 in Adult Participants With Refractory Chronic Cough, Study Study Name: Professor Anand DevarajEmail: A.Devaraj@rbht.nhs.uk. A pilot study on the role of ganglionated plexus ablation for catheter ablation of paroxysmal and persistent atrial fibrillation, Study contact information Mitochondrial dysfunction of eosinophils as a driving force for its activation in eosinophilic severe asthma, Study Aveir Dual-Chamber Leadless i2i IDE Study, Study contact information Name:Olga ArchangelidiEmail:o.archangelidi@rbht.nhs.uk, Study Name:Vladimir DomiEmail:V.Domi@rbht.nhs.uk, Study Identifying predictors for maintenance of exercise participation in children and young people with cystic fibrosis. Name:Dr Deepa ArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk. Name:Dr Brian HallidayEmail:B.Halliday@rbht.nhs.uk. Diagnosis severity & prognosis evaluation using cardiothoracic CT & MR, Study contact information Name: DrSaeedAlghamdiEmail:S.Alghamdi@rbht.nhs.uk. Name:Dr Anna ReedEmail:A.Reed@rbht.nhs.uk, Study Name:Dr Arvind SinghalEmail:A.Singhal@rbht.nhs.uk, Study Name:Dr DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator Dr. Benjamin Tam, MD, is an Orthopedic Surgery specialist practicing in Alhambra, CA with 31 years of experience. Name:Dr Brijesh PatelEmail:B.Patel4@rbht.nhs.uk. Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of patients with Pulmonary Hypertension (PH), Study contact informationName: Mr Simon PadleyEmail:S.Padley@rbht.nhs.uk. Name:Dr Ricardo JoseEmail:R.Jose@rbht.nhs.uk, Study Study Name: Michelle RackhamEmail: M.Rackham@rbht.nhs.uk, Study Study contact informationName: Dr Richard JonesEmail:r.jones@rbht.nhs.uk, Study Validating digital mobility assessment using wearable technology The Mobilise-D Clinical Validation Study. A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects with Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation. Name: Dr Brian HallidayEmail: B.Halliday@rbht.nhs.uk, Study Name:Huw EllisEmail:Huw.Ellis@rbht.nhs.uk, Study Decision support system to evaluate VENTilation in ARDS (DeVENT), Study contact information dr benjamin garfield brompton hospital - singhaniatabletting.in Dr Rodney Franklin, Study Measure of exhaled breath temperature (EBT) in patients with sarcoidosis. Your destination for buying luxury property in Voiron, Auvergne-Rhne-Alpes, France. The MISTER trial is looking at testing whether minimal equipment pulmonary rehabilitation classes are as effective as those that use specialist equipment in terms of the effect on fitness levels, breathlessness and quality of life in the short and medium term. A medical pioneer who founded Charing Cross Hospital. Royal Brompton Hospital. Breathe Plus: Testing the feasibility of a comprehensive geriatric assessment for people with COPD and frailty starting pulmonary rehabilitation, Study contact information Name:Yvonne BinghamEmail:Y.Bingham@rbht.nhs.uk, Study Prospective study in patients with pulmonary vascular disease, Study contact information Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading, Study contact informationName: Laura BarkerEmail: l.barker2@rbht.nhs.uk, Study What are common reasons for patients to see Dr. Benjamin C. Tam? A 2x2 factorial randomised single blind open labelled trial to determine the clinical and cost -effectiveness of hypertonic saline (HTS 6%) and carbocysteine versus usual care over 12 months in non-cystic fibrosis bronchiectasis (BE): The Clear study, Study Study Name:Dr Isabel SkypalaEmail:i.skypala@rbht.nhs.uk, Principal investigator Dr Isabela Skypala, Study Name: Mr Philip MolyneauxEmail: p.molyneaux@rbht.nhs.uk, Principal investigator Professor Michael Polkey, Study The EMBARC European Bronchiectasis Registry, Study Computer Tomography findings of vascular thrombosis, and abdominal organ ischemia and inflammation in Critically ill COVID-19 patients, Study contact information A Phase 3, Randomized, Double-Blind, PlaceboControlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk of Mortality. Name:Aarash SalehEmail:a.saleh@rbht.nhs.uk, Principal investigator Study Court'ea CRDITS voiron . Neuromuscular electrical stimulation (NMES) is a portable hand-held muscle stimulator which allows the thigh muscles to be exercised whilst seated. Studying the microbiome of the lung in patients treated with endobronchial lung volume reduction coils for emphysema, Study contact information Randomised Evaluation of COVID-19 Therapy (RECOVERY), Study contact information Singing for Health: Improving Experience of Lung Disease, Study contact information Study contact information Study Dr Andres Rico-Armada, Study ROR-PH-303 - A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION, Study Liste des Hpitaux en Saint-Marcellin, Auvergne-Rhne-Alpes . Name:Brian HallidayEmail:B.Halliday@rbht.nhs.uk, Study Name:Joanne BentonEmail:j.benton@rbht.nhs.uk, Study Study Books. The Oxford Risk Factors And Non-invasive imaging Study. Name: Alkida BucajEmail: A.Bucaj@rbht.nhs.uk, Principal investigator TrIFIC: Targeting Immunotherapy for Fungal Infection in Cystic Fibrosis, Study contact information Digital tools in Heart failure a survey of patient usage, Study contact information Understanding susceptibility to fungal infection and evolution of antimicrobial resistance in chronic respiratory disease, Study contact information A Phase 3, multinational, randomised, placebo-controlled study of ARRY-371797 in patients with Symptomatic Dilated Cardiomyopathy due to a Lamin A/C Gene Mutation, Study contact informationName: Dr James WareEmail: J.Ware@rbht.nhs.uk, Study contact information Name:Dr Tom WongEmail:T.Wong2@rbht.nhs.uk, Study contact information Dr Samantha Irving, Study Catheter versus thoracoscopic surgical ablation in long standing persistent Atrial Fibrillation - multicentre randomised control trial, Study The London COPD cohort respiratory syncytial virus (RSV) study, Study contact information Name:Angela GallagherEmail:a.gallagher2@rbht.nhs.uk, Principal investigator Name:Dr GiuliaCrapelliEmail:G.Crapelli@rbht.nhs.uk, Principal investigator Name:Ethaar El-EmirEmail:E.El-Emir@rbht.nhs.uk, Study Prevalence of Pompes disease amongst patients with unexplained respiratory muscle weakness or respiratory failure, Study contact information Name: Pujan PatelEmail: p.patel@rbht.nhs.uk, Study HEmodynamic effects of Reducing lv Afterload with impella or intra-aortic balloon CounterpuLsation during veno-arterial Extracorporeal membrane oxygenation in cardiogenic Shock, Study contact information PAciFy Cough: A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough, Study contact informationName:Zhe WuEmail:Z.Wu@rbht.nhs.uk. Name:Richard MordiEmail:R.Mordi@rbht.nhs.uk, Study Examining the use and yield of genetic testing in clinical practice for patients with dilated cardiomyopathy. COVID-19 as a Trigger/Risk Factor in Acute Coronary Syndromes, Study contact information This provider currently accepts 50 insurance plans including Medicare and Medicaid. Name: Najwa SoussiEmail:n.soussi@rbht.nhs.uk. Dr Stephen John Wort, Study Utility of Emphasis-10 in Risk Stratification in Pulmonary Arterial Hypertension. Six Month Mortality in Patients with COVID-19 and Non-COVID-19 - PubMed Dr. Bloom specializes in the care of adults with congenital heart disease (ACHD). An observational study of neurodevelopmental outcome after cardiac arrest in children admitted to paediatric intensive care, Study contact information The Effects of inorganic nitrite on cardiac and skeletal muscle: Physiology, pharmacology, and therapeutic potential in patients with Chronic Heart Failure, Study contact information A randomised, subject- and investigator-blinded, placebo controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of QBW251 in patients with bronchiectasis, Study Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction (PiCSO-AMI-I), Study contact informationName: Paula RogersEmail:p.rogers@rbht.nhs.uk, Study As well as developing new treatments and procedures, they teach, lecture and publish articles around the world. Study Study Growing up on non-invasive ventilation: assessment of multisystem and autonomic complications of neuromuscular and neurological disorders in young adults. Study Name:Dexter WisemanEmail:D.Wiseman@rbht.nhs.uk, Principal investigator Name:ChrisRemmingtonEmail:C.Remmington@rbht.nhs.uk, Study Multiple Breath Washout in paediatric chronic airways disease: Building a clinimetrics dataset, Study contact information Does Extra-Corporeal Membrane Oxygenation alter anti-infectives therapy pharmacokinetics in adult critically ill patients? Potential for personalised application of inhaled nitric oxide in COVID Name:CharisBrowneEmail:C.Browne@rbht.nhs.uk, Study Study Iron and Chronic Obstructive Pulmonary Disease (COPD) exercise trial, Study contact information Narratives of NHS nurses working in ICUs during the COVID-19 pandemic, Study contact information Co-Design of a Pulmonary Rehabilitation intervention to Improve outcomes post-Exacerbation in Bronchiectasis, Study contact information A phase iii randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of prm-151 in patients with Idiopathic Pulmonary Fibrosis. A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib, 150 mg twice daily for 52 weeks (with follow up until last patient out up to a maximum of 2 years) in patients with systemic sclerosis associated interstitial lung disease, Study contact information Rocourt Jean-Baptiste . Weaning from mechanical ventilation: comparison of open-loop decision support system and routine care in cardiothoracic patients. Do patterns of airway infection and inflammation distinguish pathophysiological phenotypes in children with wheeze and asthma? Professor Dudley Pennell. Tracking non small cell lung cancer evolution through therapy (Rx), Study contact information Dr. Benjamin C. Tam, MD | Pacific Orthopedic, Alahambra, CA - Zocdoc The study, the largest of its kind worldwide, was led at by Dr Laura Price, consultant physician for pulmonary hypertension, and by Dr Benjamin Garfield, consultant in critical care. Name:Gemma StanfordEmail:G.Stanford@rbht.nhs.uk, Principal investigator Study Study contact informationName: Mr Zain OdhoEmail: Z.Odho@rbht.nhs.uk. PaEdiatric TRAnsfusion practices in PICU in UK (PETRA-UK study), Study contact information A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of CK3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction, Study contact information Deep learning for HRCT classification of fibrotic lung disease, Study Professor Mahmoud Barbir. Name:Merriel WoodruffEmail:M.Woodruff@rbht.nhs.uk, Study Name:Ashraf HussainEmail:A.Hussain@rbht.nhs.uk, Principal investigator Name: Carmen ChanEmail: l.chan2@rbht.nhs.uk, Principal investigator Name:Dr Sandra Gala-PeraltaEmail:s.gala-peralta@rbht.nhs.uk, Principal investigator dr benjamin garfield brompton hospital. Childhood Home Asthma Monitoring Project: prospective observational study to explore the use of contactless home monitoring devices and analysis to predict asthma risk, Study contact information by . National Study of prenatally diagnosed right aortic arch and double arch: Incidence; associations and outcomes. Multicentre, open-label, active-controlled, randomised study to evaluate the efficacy and safety of an age and body weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism, Study contact information Identifying progressive fibrosing lung disease: a study of genetic and environmental interactions: an observational cohort study. Severe wheeze and asthma validation study, Study contact information Study He also had the brilliant and revolutionary idea of integrating medical schools with hospitals, to ensure people would be treated effectively now and in future. Name: Dr Christopher OrtonEmail:c.orton@rbht.nhs.uk, Study Royal Brompton & Harefield Hospitals Specialist Care | London - Facebook Professor Anita Simonds, Study Autoantibody Predictors of Long-Term Outcomes in Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease. Dr Rosemary Boyton, Study Name: Sally MeahEmail: S.Meah@rbht.nhs.uk, Study contact information Real World Study of the Tendyne Mitral Valve System to Treat Mitral Regurgitation (Tendyne PMCF Study), Principal investigator Clustering and Phenotyping Interstitial Lung Disease, Study contact information Phase III PoCC pivotal trial #1 BI 1015550 - PDE4 inhibitor in AF experienced PF-ILD. Coronary sinus reducer Objective impact on Symptoms, MRI Ischaemia and microvascular Resistance, Study contact informationName: Dr Ranil De SilvaEmail: r.desilva2@rbht.nhs.uk. Dr Nicholas Simmonds. Study contact information He graduated with honors in 2018. Jordan Bloom, MD, MPH - Massachusetts General Hospital Study contact informationName: Sally MeahEmail:sally.meah@imperial.ac.uk, Study An open-label study to assess the safety, pharmacokinetics and pharmacodynamics of inhaled PC945 in adult Cystic Fibrosis (CF) patients with persistent pulmonary Aspergillus fumigatus infection, Study contact information Genetic linkage evaluation in inherited cardiac conditions, Study contact information His practice is broad and covers a variety of congenital disorders including connective . Principal investigator Genetics of susceptibility and mortality in critical care, Study contact informationName:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Inherited Cardiac cONditions In Kids Understanding the Genetics and Outcomes of Paediatric Inherited Cardiac Conditions, Study contact information Name:Paula RogersEmail: p.rogers@rbht.nhs.uk, Study Dr Elizabeth Renzoni. Advanced Search. Name: Joy PinguelEmail: A.Pinguel@rbht.nhs.uk, Study Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF). Professor Anand Devaraj, Study Name: Dr Robert SmithEmail: r.smith@rbht.nhs.uk, Study Study contact information Multicenter, open-label, single dose study to evaluate the safety, tolerability and pharmacokinetics of LCZ696 followed by randomised, double-blind, parallel group,active-controlled study to evaluate the efficacy and safety of LCZ696 in pediatric patients, Study contact information Study A Phase 2 Study of Efficacy and Safety of AX-8 in Chronic Cough. Dr Darius Armstrong-James, Study Study Dr Christoph Nienaber, Study Study Professor Piers Daubeney, Study Dr Stephen John Wort, Study Study Study contact information High density substrate evaluation and guided ablation therapy for atrial fibrillation: Heat-AF, Study contact informationName:Dr Haseeb ValliEmail:H.Valli@rbht.nhs.uk, Study A pragmatic approach to the investigation of stable chest pain: a UK, multi-centre, randomised trial to improve patient experience, outcomes and NHS cost efficiency, Study contact information Post-hospitalisation COVID-19 study: a national consortium to understand and improve long-term health outcomes. Identifying a safe and tolerated dose of Imatinib for patients with Pulmonary Arterial Hypertension (PAH), Study Study Name: Angela JamalzadehEmail: a.jamalzadeh@rbht.nhs.uk, Study Name:Rachel SteadEmail:R.Stead@rbht.nhs.uk, Study Affiliations 1 From the Department of Adult Intensive Care, Royal Brompton & Harefield Hospitals, part of Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom. Dr Philip Molyneaux, Study Dr Hatem Soliman Aboumarie & Dr Sian Jaggar, Study Optimising cancer treatment surveillance and ascertaining cause of Pneumonitis using artificial intelligence, Study Professor Martin Cowie, Study Professor Toby Maher. Hospital affiliations include Lakewood Regional Medical Center. A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of BG00011 in patients with Idiopathic Pulmonary Fibrosis. Does a pedometer-based walking programme affect exercise capacity and quality of life in sedentary adults with congenital heart disease? Affiliated Hospitals Medical Group Practices Practice Location 707 S Garfield Ave Alhambra, California 91801-4438 Map and Directions Phone: (626) 458-6653 Fax: (626) 289-5700 Office Hours: Monday - Friday: 8:00 AM - 5:00 PM Saturday - Sunday: Closed A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study contact information Name:Dr Justin GarnerEmail:J.Garner@rbht.nhs.uk, Study Assessing Organisational Readiness for Heart Failure Remote Monitoring, Study contact information dr benjamin garfield brompton hospital. An open-label randomised, parallel-group, multicenter, observational trial to evaluate the safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac disease at risk of thromboembolic events. 4D Flow Cardiovascular Magnetic Resonance analysis of the right ventricle in lung transplant assessment, Study contact information Study A Randomised, Double-Blind, Placebo-Controlled, Phase 1b, Dose Escalation, Safety, Tolerability and Pharmacodynamic Biomarker Study of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Recently Diagnosed, Treatment Nave Subjects with Idiopathic Pulmonary Fibrosis. Study contact informationName:Lyn PaulEmail:l.paul@rbht.nhs.uk. Investigation of the molecular and cellular pathogenesis of bone marrow failure syndromes, Study contact information
James O'keefe Married To Beverley Knight,
How Long Do Asos Refunds Take,
Articles D